diagnostics
Healthcare
How diagnostics companies can drive efficiency as price caps loom
With the spectre of the National Essential Diagnostics List and price caps looming over diagnostics industry, margins may come under ......
Healthcare
Diagnostics firms shouldn't fear price controls: Panellists at VCCircle summit
Diagnostics companies must focus on providing good-quality services and building sustainable business models instead of worrying about government moves to ......
Healthcare
WestBridge-backed Dr Lal PathLabs to acquire majority stake in Indore lab
Diagnostics chain Dr Lal PathLabs Ltd said on Friday it will acquire a 70% stake in a new company that ......
Healthcare
Dr Lal PathLabs CEO on acquisition plans and declining PE interest in diagnostics
Dr Lal PathLabs Ltd, which became the first Indian diagnostics chain to list on the stock exchanges in 2015, has ......
Healthcare
Carlyle-backed Metropolis' IPO subscribed almost six times on final day
Pathology chain owner Metropolis Healthcare Ltd’s initial public offering (IPO) was subscribed almost six times on the third and final ......
Healthcare
Carlyle-backed Metropolis Healthcare's IPO nears halfway mark on second day
Pathology chain owner Metropolis Healthcare Ltd’s initial public offering (IPO) nearly reached the halfway mark on its second day on ......
Healthcare
Carlyle-backed Metropolis Healthcare's IPO covered 9% on first day
Pathology chain operator Metropolis Healthcare Ltd’s initial public offering (IPO) began on a slow note on its first day of ......
Healthcare
CDPQ, Edelweiss PE come in as anchor investors in Metropolis Healthcare ahead of IPO
Canadian pension fund Caisse de dépôt et placement du Québec (CDPQ) and the private equity arm of Edelweiss Financial Services ......
Healthcare
Value Lens: How does Metropolis Healthcare size up against listed peers?
When Metropolis Healthcare Ltd goes public next week, it will become the third diagnostics chain to launch an initial public ......
Healthcare
Tracing Carlyle's returns from partial exit in Metropolis' upcoming IPO
US-headquartered private equity giant The Carlyle Group appears likely to score modest returns from the sale of a little more ......
